Results 181 to 190 of about 26,503 (228)

Real-World Outcomes across Baseline Risk Profiles in Patients with COPD Initiating Budesonide/Glycopyrronium/Formoterol Fumarate Dihydrate in Spain: Insights from the ORESTES Study. [PDF]

Pulm Ther
Alcázar-Navarrete B, Figueira-Gonçalves JM, Blanco Cid N, Bruguera Avila N, Bernabeu Mora R, Fuster Gomila A, Galera Martínez R, García Clemente MM, Granados G, Khadour Khadour H, Márquez-Martín E, Murga Arizabaleta I, Velasco Garrido JL, Corregidor-García C, Fitas E, Sánchez-Covisa J.   +15 more
europepmc   +1 more source

Treatment patterns of eosinophilic esophagitis in the biologic era-a real-world analysis. [PDF]

Dis Esophagus
Pokryszka J, Weitersberger M, Dinkhauser P, Steidl K, Horvatits T, Haefner M, Kazemi-Shirazi L, Novacek G, Trauner M, Sieghart W, Schlager H, Schreiner P.   +11 more
europepmc   +1 more source

Perioperative nebulized budesonide and L-Cysteine reduce pulmonary complications after posterior skull base tumor resection: a randomized controlled trial. [PDF]

BMC Anesthesiol
Wu S, Richard SA, Lan Z.
europepmc   +1 more source

Fluticasone- vs Budesonide-Based Dual Therapy for COPD.

JAMA Netw Open
Feldman WB, Ambati VL, Suissa S, Kesselheim AS, Avorn J, Schneeweiss S, Wang SV.   +6 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Budesonide

Drugs, 2012
Donna Mctavish, Rex N Brogden, R N Brogden   +2 more
exaly   +2 more sources

Adjustable maintenance dosing with budesonide/formoterol or budesonide: Double-blind study [PDF]

Respiratory Medicine, 2006
SummaryAdjustable maintenance dosing with either budesonide/formoterol or budesonide was compared in asthma patients.This double-blind trial randomized 133 patients (mean forced expiratory volume in 1s 66% predicted) to receive 2 inhalations twice daily ...
H. Zwick, Pohl, W.R., N. Vetter, Hrubos, W., Vetter, N., W. Hrubos, W.R. Pohl, Zwick, H.   +7 more
exaly   +2 more sources

Efficacy and safety of budesonide/formoterol single inhaler therapy versus a higher dose of budesonide in moderate to severe asthma

Current Medical Research and Opinion, 2004
Objectives:This study evaluated the efficacy and safety of a novel asthma management strategy - budesonide/formoterol for both maintenance and symptom relief (Symbicort Single Inhaler Therapy*) - compared with a higher maintenance dose of budesonide in ...
L-P Boulet, D Ukena, R Aalbers
exaly   +2 more sources

Once-daily dosing with budesonide/formoterol compared with twice-daily budesonide/formoterol and once-daily budesonide in adults with mild to moderate asthma [PDF]

Respiratory Medicine, 2006
SummaryAdherence to maintenance therapy is often poor in patients with asthma. Simplifying dosing regimens has the potential to improve both adherence and asthma-related morbidity.
Piotr Kuna, U Nihlén, A Lindqvist
exaly   +2 more sources

Efficacy of liposomal budesonide in experimental asthma

Journal of Allergy and Clinical Immunology, 2003
Background: Inhaled corticosteroids, such as budesonide, attenuate the inflammatory response in asthma. However, patient noncompliance and side effects of available inhaled corticosteroids limit their use.
Nejat Düzgüneş
exaly   +2 more sources

Budesonide

Reactions Weekly, 2023
  +4 more sources